The comparison across multiple neurodegenerative diseases suggest that convergent mechanisms between AD and CTE such as pathologic protein deposition and normal aging can also increase CCL2 levels through mechanisms distinct from RHI. Here, CCL2 is linked to Alzheimer disease.